RxDoctor Payments Data

Emily Bergeron

Primary Care · Franklin, LANPI 1033627906

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,085, 7.8 times the $140 reported in 2021.

$1,364in general payments, 2019–2025

Across 40 payments — averaging $34.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$269
  • Teva Pharmaceuticals USA, Inc.$194
  • Exact Sciences$182
  • UCB, Inc.$122
  • Axsome Therapeutics, Inc.$98
  • Johnson & Johnson$87
  • plus $413 from 11 others

What the payments were for

  • Food & beverage$1,364100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,364 in reported general payments places this provider in the 65th percentile of 106 primary care providers in Louisiana.

See all primary care providers in Louisiana

Medicare billing

Part B allowed, 2024
$1,684
Medicare patients
35
Services billed
212

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide130$135,223
JardianceEmpagliflozin92$109,176
MounjaroTirzepatide35$37,476
JanuviaSitagliptin Phosphate36$36,000
TrulicityDulaglutide17$16,578
FarxigaDapagliflozin Propanediol15$13,673
Albuterol Sulfate HfaAlbuterol Sulfate72$2,029
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$1,605
Ventolin HfaAlbuterol Sulfate18$1,034
Rosuvastatin Calcium138$1,006
Famotidine46$823
Olmesartan Medoxomil75$813
Amlodipine Besylate114$782
Lisinopril90$656
Metformin Hcl ErMetformin Hcl45$619

Paid to pharmacies, not to this prescriber.

Other primary care in Franklin

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →